Group 1 - The core viewpoint of the news is that Sanbo Brain Science has seen a significant increase in its stock price, reaching 60.18 yuan, with a rise of 4.82%, while its rolling PE ratio has dropped to a new low of 112.80 times over the past 309 days, with a total market value of 12.396 billion yuan [1] - In terms of industry comparison, the average PE ratio for the medical services sector is 48.17 times, and the median is 63.54 times, placing Sanbo Brain Science at the 38th position within the industry [1] - The company experienced a net outflow of 3.9494 million yuan in principal funds on August 12, with a total outflow of 311.8002 million yuan over the past five days [1] Group 2 - Sanbo Brain Science Hospital Management Group Co., Ltd. primarily engages in clinical medical services, with its main products including medical services, pharmaceuticals, supply chain, and other businesses [1] - The latest performance report for the first quarter of 2025 indicates that the company achieved an operating income of 393 million yuan, representing a year-on-year increase of 16.78%, and a net profit of 38.3136 million yuan, up 14.56%, with a sales gross margin of 26.44% [1]
三博脑科收盘上涨4.82%,滚动市盈率112.80倍,总市值123.96亿元